Michael Turchin
About Michael Turchin
Michael Turchin is a Senior Scientist in Statistical Genetics at Bristol Myers Squibb, with over a decade of experience in genetic research and a focus on autoimmune, fibrotic, and cardiovascular diseases.
Title
Michael Turchin is currently a Senior Scientist in Statistical Genetics at Bristol Myers Squibb, based in Cambridge, Massachusetts.
Company
Michael Turchin works at Bristol Myers Squibb, a globally recognized biopharmaceutical company focused on discovering, developing, and delivering innovative medicines.
Education and Expertise
Michael Turchin holds a Doctor of Philosophy (PhD) in Human Genetics from the University of Chicago, where he studied from 2011 to 2017. He also graduated magna cum laude with a Bachelor of Science (BSc) in Biological Sciences and Animal Science from Cornell University, where he studied from 2005 to 2009. His research focuses on integrating diverse -omics data with genetics to create new frameworks for discovering high-impact drug targets.
Background
Michael Turchin has extensive experience in academic research, having worked in various research positions over the years. He served as a Postdoctoral Fellow at the Icahn School of Medicine at Mount Sinai in New York from 2020 to 2021 and as a Postdoctoral Researcher at Brown University from 2017 to 2020. He also worked as a Graduate Researcher at the University of Chicago from 2011 to 2017, a Research Assistant at both Children's Hospital Boston and the Broad Institute from 2009 to 2011, and an Undergraduate Researcher at Cornell University from 2006 to 2009.
Research and Development
Michael Turchin has developed polygenic risk scores to identify relevant patient subsets and characteristics for clinical trials. He is focused on improving early-stage clinical pipeline processes and specializes in clinical areas including autoimmune, fibrotic, and cardiovascular diseases.